GO:0016071 | mRNA metabolic process | 1.03e-09 | 1.49e-05 | 5.430 | 6 | 31 | 223 |
GO:0016070 | RNA metabolic process | 1.91e-09 | 2.76e-05 | 5.283 | 6 | 32 | 247 |
GO:0005829 | cytosol | 1.38e-07 | 1.98e-03 | 2.531 | 9 | 132 | 2496 |
GO:0016032 | viral process | 1.91e-07 | 2.76e-03 | 4.170 | 6 | 55 | 534 |
GO:0016020 | membrane | 2.71e-07 | 3.91e-03 | 2.931 | 8 | 90 | 1681 |
GO:0010467 | gene expression | 7.26e-07 | 1.05e-02 | 3.845 | 6 | 59 | 669 |
GO:0006521 | regulation of cellular amino acid metabolic process | 3.25e-06 | 4.68e-02 | 6.587 | 3 | 17 | 50 |
GO:0070062 | extracellular vesicular exosome | 4.47e-06 | 6.44e-02 | 2.417 | 8 | 104 | 2400 |
GO:0000502 | proteasome complex | 5.10e-06 | 7.35e-02 | 6.373 | 3 | 17 | 58 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 6.87e-06 | 9.91e-02 | 6.231 | 3 | 19 | 64 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 7.20e-06 | 1.04e-01 | 6.209 | 3 | 22 | 65 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 9.01e-06 | 1.30e-01 | 6.102 | 3 | 22 | 70 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 9.81e-06 | 1.41e-01 | 6.061 | 3 | 20 | 72 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.07e-05 | 1.54e-01 | 6.022 | 3 | 22 | 74 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 1.11e-05 | 1.60e-01 | 6.002 | 3 | 20 | 75 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.30e-05 | 1.87e-01 | 5.927 | 3 | 23 | 79 |
GO:0019083 | viral transcription | 1.40e-05 | 2.02e-01 | 5.891 | 3 | 10 | 81 |
GO:0006415 | translational termination | 1.73e-05 | 2.50e-01 | 5.788 | 3 | 10 | 87 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 2.05e-05 | 2.96e-01 | 5.708 | 3 | 21 | 92 |
GO:0006414 | translational elongation | 2.12e-05 | 3.06e-01 | 5.692 | 3 | 13 | 93 |
GO:0005838 | proteasome regulatory particle | 2.28e-05 | 3.28e-01 | 8.061 | 2 | 7 | 12 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 2.96e-05 | 4.28e-01 | 5.531 | 3 | 10 | 104 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 3.90e-05 | 5.63e-01 | 5.398 | 3 | 11 | 114 |
GO:0019058 | viral life cycle | 4.01e-05 | 5.78e-01 | 5.386 | 3 | 13 | 115 |
GO:0000209 | protein polyubiquitination | 4.11e-05 | 5.93e-01 | 5.373 | 3 | 20 | 116 |
GO:0022624 | proteasome accessory complex | 4.68e-05 | 6.76e-01 | 7.559 | 2 | 8 | 17 |
GO:0006413 | translational initiation | 5.91e-05 | 8.52e-01 | 5.198 | 3 | 17 | 131 |
GO:0000278 | mitotic cell cycle | 6.02e-05 | 8.68e-01 | 4.035 | 4 | 48 | 391 |
GO:0003735 | structural constituent of ribosome | 6.75e-05 | 9.74e-01 | 5.133 | 3 | 10 | 137 |
GO:0000082 | G1/S transition of mitotic cell cycle | 8.67e-05 | 1.00e+00 | 5.012 | 3 | 32 | 149 |
GO:0042981 | regulation of apoptotic process | 8.85e-05 | 1.00e+00 | 5.002 | 3 | 24 | 150 |
GO:0044267 | cellular protein metabolic process | 1.27e-04 | 1.00e+00 | 3.757 | 4 | 29 | 474 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.31e-04 | 1.00e+00 | 4.813 | 3 | 20 | 171 |
GO:0005654 | nucleoplasm | 2.30e-04 | 1.00e+00 | 2.889 | 5 | 76 | 1082 |
GO:0022627 | cytosolic small ribosomal subunit | 2.53e-04 | 1.00e+00 | 6.361 | 2 | 4 | 39 |
GO:0006412 | translation | 3.13e-04 | 1.00e+00 | 4.386 | 3 | 20 | 230 |
GO:0019521 | D-gluconate metabolic process | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0000461 | endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:0019322 | pentose biosynthetic process | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 2 | 2 |
GO:0005055 | laminin receptor activity | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:0006407 | rRNA export from nucleus | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:0043066 | negative regulation of apoptotic process | 1.86e-03 | 1.00e+00 | 3.503 | 3 | 31 | 424 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 1.87e-03 | 1.00e+00 | 9.061 | 1 | 2 | 3 |
GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity | 1.87e-03 | 1.00e+00 | 9.061 | 1 | 1 | 3 |
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 4 |
GO:0030686 | 90S preribosome | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 4 |
GO:0043248 | proteasome assembly | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 5 |
GO:0030957 | Tat protein binding | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 3 | 6 |
GO:0006915 | apoptotic process | 4.00e-03 | 1.00e+00 | 3.115 | 3 | 33 | 555 |
GO:0000028 | ribosomal small subunit assembly | 4.36e-03 | 1.00e+00 | 7.839 | 1 | 1 | 7 |
GO:0044281 | small molecule metabolic process | 4.42e-03 | 1.00e+00 | 2.404 | 4 | 58 | 1211 |
GO:0070688 | MLL5-L complex | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 8 |
GO:0006098 | pentose-phosphate shunt | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 4 | 10 |
GO:0042273 | ribosomal large subunit biogenesis | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 4 | 13 |
GO:0030234 | enzyme regulator activity | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 3 | 13 |
GO:0035267 | NuA4 histone acetyltransferase complex | 8.70e-03 | 1.00e+00 | 6.839 | 1 | 4 | 14 |
GO:0050998 | nitric-oxide synthase binding | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 16 |
GO:0042176 | regulation of protein catabolic process | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 3 | 16 |
GO:0010243 | response to organonitrogen compound | 1.06e-02 | 1.00e+00 | 6.559 | 1 | 3 | 17 |
GO:0005839 | proteasome core complex | 1.12e-02 | 1.00e+00 | 6.476 | 1 | 8 | 18 |
GO:0004298 | threonine-type endopeptidase activity | 1.18e-02 | 1.00e+00 | 6.398 | 1 | 8 | 19 |
GO:0048863 | stem cell differentiation | 1.18e-02 | 1.00e+00 | 6.398 | 1 | 1 | 19 |
GO:0043029 | T cell homeostasis | 1.30e-02 | 1.00e+00 | 6.254 | 1 | 1 | 21 |
GO:0030863 | cortical cytoskeleton | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 1 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 4 | 22 |
GO:0043044 | ATP-dependent chromatin remodeling | 1.43e-02 | 1.00e+00 | 6.123 | 1 | 4 | 23 |
GO:0043236 | laminin binding | 1.43e-02 | 1.00e+00 | 6.123 | 1 | 1 | 23 |
GO:0040007 | growth | 1.55e-02 | 1.00e+00 | 6.002 | 1 | 2 | 25 |
GO:0019901 | protein kinase binding | 1.57e-02 | 1.00e+00 | 3.338 | 2 | 21 | 317 |
GO:0031492 | nucleosomal DNA binding | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 4 | 27 |
GO:0019843 | rRNA binding | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 3 | 27 |
GO:0043022 | ribosome binding | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 3 | 27 |
GO:0050661 | NADP binding | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 2 | 27 |
GO:0019894 | kinesin binding | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 1 | 28 |
GO:0005925 | focal adhesion | 2.05e-02 | 1.00e+00 | 3.130 | 2 | 19 | 366 |
GO:0001895 | retina homeostasis | 2.10e-02 | 1.00e+00 | 5.559 | 1 | 1 | 34 |
GO:0034332 | adherens junction organization | 2.22e-02 | 1.00e+00 | 5.476 | 1 | 1 | 36 |
GO:0007077 | mitotic nuclear envelope disassembly | 2.22e-02 | 1.00e+00 | 5.476 | 1 | 1 | 36 |
GO:0048538 | thymus development | 2.22e-02 | 1.00e+00 | 5.476 | 1 | 2 | 36 |
GO:0051084 | 'de novo' posttranslational protein folding | 2.29e-02 | 1.00e+00 | 5.437 | 1 | 4 | 37 |
GO:0070527 | platelet aggregation | 2.35e-02 | 1.00e+00 | 5.398 | 1 | 2 | 38 |
GO:0044822 | poly(A) RNA binding | 2.35e-02 | 1.00e+00 | 2.187 | 3 | 49 | 1056 |
GO:0014070 | response to organic cyclic compound | 2.65e-02 | 1.00e+00 | 5.220 | 1 | 4 | 43 |
GO:0021762 | substantia nigra development | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 2 | 44 |
GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity | 2.77e-02 | 1.00e+00 | 5.154 | 1 | 2 | 45 |
GO:0022625 | cytosolic large ribosomal subunit | 3.02e-02 | 1.00e+00 | 5.031 | 1 | 6 | 49 |
GO:0005515 | protein binding | 3.23e-02 | 1.00e+00 | 0.897 | 7 | 184 | 6024 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 3.26e-02 | 1.00e+00 | 4.918 | 1 | 5 | 53 |
GO:0045216 | cell-cell junction organization | 3.32e-02 | 1.00e+00 | 4.891 | 1 | 2 | 54 |
GO:0005840 | ribosome | 3.56e-02 | 1.00e+00 | 4.788 | 1 | 1 | 58 |
GO:0034329 | cell junction assembly | 4.17e-02 | 1.00e+00 | 4.559 | 1 | 1 | 68 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 4.53e-02 | 1.00e+00 | 4.437 | 1 | 6 | 74 |
GO:0005200 | structural constituent of cytoskeleton | 5.54e-02 | 1.00e+00 | 4.138 | 1 | 8 | 91 |
GO:0006928 | cellular component movement | 5.54e-02 | 1.00e+00 | 4.138 | 1 | 7 | 91 |
GO:0001649 | osteoblast differentiation | 5.60e-02 | 1.00e+00 | 4.123 | 1 | 6 | 92 |
GO:0006364 | rRNA processing | 5.72e-02 | 1.00e+00 | 4.092 | 1 | 6 | 94 |
GO:0051726 | regulation of cell cycle | 5.89e-02 | 1.00e+00 | 4.046 | 1 | 5 | 97 |
GO:0014069 | postsynaptic density | 6.37e-02 | 1.00e+00 | 3.932 | 1 | 3 | 105 |
GO:0015630 | microtubule cytoskeleton | 6.66e-02 | 1.00e+00 | 3.865 | 1 | 4 | 110 |
GO:0072562 | blood microparticle | 6.72e-02 | 1.00e+00 | 3.852 | 1 | 3 | 111 |
GO:0030529 | ribonucleoprotein complex | 6.78e-02 | 1.00e+00 | 3.839 | 1 | 8 | 112 |
GO:0006325 | chromatin organization | 7.13e-02 | 1.00e+00 | 3.764 | 1 | 5 | 118 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 7.60e-02 | 1.00e+00 | 3.669 | 1 | 5 | 126 |
GO:0000790 | nuclear chromatin | 7.77e-02 | 1.00e+00 | 3.635 | 1 | 9 | 129 |
GO:0000086 | G2/M transition of mitotic cell cycle | 8.18e-02 | 1.00e+00 | 3.559 | 1 | 9 | 136 |
GO:0006457 | protein folding | 8.58e-02 | 1.00e+00 | 3.486 | 1 | 7 | 143 |
GO:0061024 | membrane organization | 8.69e-02 | 1.00e+00 | 3.466 | 1 | 7 | 145 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 9.84e-02 | 1.00e+00 | 3.280 | 1 | 7 | 165 |
GO:0030424 | axon | 9.90e-02 | 1.00e+00 | 3.271 | 1 | 4 | 166 |
GO:0001701 | in utero embryonic development | 1.19e-01 | 1.00e+00 | 2.995 | 1 | 8 | 201 |
GO:0005634 | nucleus | 1.20e-01 | 1.00e+00 | 0.814 | 5 | 136 | 4559 |
GO:0007067 | mitotic nuclear division | 1.33e-01 | 1.00e+00 | 2.820 | 1 | 14 | 227 |
GO:0005975 | carbohydrate metabolic process | 1.47e-01 | 1.00e+00 | 2.663 | 1 | 9 | 253 |
GO:0005856 | cytoskeleton | 1.68e-01 | 1.00e+00 | 2.461 | 1 | 12 | 291 |
GO:0043234 | protein complex | 1.70e-01 | 1.00e+00 | 2.442 | 1 | 18 | 295 |
GO:0007411 | axon guidance | 1.82e-01 | 1.00e+00 | 2.329 | 1 | 13 | 319 |
GO:0005813 | centrosome | 1.86e-01 | 1.00e+00 | 2.297 | 1 | 14 | 326 |
GO:0005737 | cytoplasm | 1.87e-01 | 1.00e+00 | 0.767 | 4 | 110 | 3767 |
GO:0003723 | RNA binding | 1.94e-01 | 1.00e+00 | 2.228 | 1 | 20 | 342 |
GO:0007155 | cell adhesion | 2.08e-01 | 1.00e+00 | 2.119 | 1 | 6 | 369 |
GO:0055114 | oxidation-reduction process | 2.34e-01 | 1.00e+00 | 1.932 | 1 | 12 | 420 |
GO:0007596 | blood coagulation | 2.51e-01 | 1.00e+00 | 1.816 | 1 | 18 | 455 |
GO:0005730 | nucleolus | 2.73e-01 | 1.00e+00 | 0.966 | 2 | 69 | 1641 |
GO:0045087 | innate immune response | 3.16e-01 | 1.00e+00 | 1.427 | 1 | 24 | 596 |
GO:0005615 | extracellular space | 4.61e-01 | 1.00e+00 | 0.744 | 1 | 17 | 957 |
GO:0005524 | ATP binding | 5.72e-01 | 1.00e+00 | 0.304 | 1 | 60 | 1298 |
GO:0005886 | plasma membrane | 8.31e-01 | 1.00e+00 | -0.688 | 1 | 45 | 2582 |